Abstract: A driver seat airbag device that includes an occupant side panel of a cushion having a larger surface area than that of a steering wheel side panel and a side surface panel that forms the side surface of the cushion; the occupant side panel includes a depressed section recessed toward the steering wheel side and a bulged section in a ring shape positioned surrounding the depressed section; where based on prescribed means pulling toward the steering wheel side, a center area closest to the steering wheel and a first inclined area sloped in a flared shaped from the center area toward the occupant side are formed in the depressed section and a second inclined area continuous with the first inclined area is formed in the bulged section; and the center area and first and second inclined areas restrain the head of the occupant.

Abstract: A driver seat airbag device that includes an occupant side panel of a cushion having a larger surface area than that of a steering wheel side panel and a side surface panel that forms the side surface of the cushion; the occupant side panel includes a depressed section recessed toward the steering wheel side and a bulged section in a ring shape positioned surrounding the depressed section; where based on prescribed means pulling toward the steering wheel side, a center area closest to the steering wheel and a first inclined area sloped in a flared shaped from the center area toward the occupant side are formed in the depressed section and a second inclined area continuous with the first inclined area is formed in the bulged section; and the center area and first and second inclined areas restrain the head of the occupant.

Abstract: In a driver's seat airbag apparatus for vehicles, which includes a driver airbag which is deployed and expanded from a hub region towards a driver's seat via the inner peripheral side of a rim of a steering wheel surrounding this hub region, the driver airbag is configured so as to include: a back panel which is attached and fixed to an inflator provided in the hub region, and a bag body which is provided so as to be bonded to this back panel and deployed and expanded from this back panel towards the driver's seat, and wherein the attachment center S of the inflator to this back panel is set with respect to the center P of the back panel so as to be close to the 6 o'clock direction side in the 12 o'clock direction and the 6 o'clock direction of the steering wheel.

Abstract: An active vent mechanism for an airbag apparatus that includes a first vent hole formed in an airbag and a patch capable of releasing and closing the first vent hole. A portion of the patch is coupled to the outer surface of the airbag. The airbag apparatus includes a coupling member having one end coupled to the patch and the other end entering the airbag and coupled to the airbag. A portion of the patch or a portion of the coupling member penetrates through an opening in the vicinity of the first vent hole. The airbag apparatus includes a substantially cylindrical regulating member into which the coupling member is inserted inside the airbag. The regulating member has a first end coupled to the inner surface of the airbag so as to surround the opening inside the airbag and a second end coupled to the coupling member in a sealed state.

Abstract: In a driver's seat airbag apparatus for vehicles, which includes a driver airbag which is deployed and expanded from a hub region towards a driver's seat via the inner peripheral side of a rim of a steering wheel surrounding this hub region, the driver airbag is configured so as to include: a back panel which is attached and fixed to an inflator provided in the hub region, and a bag body which is provided so as to be bonded to this back panel and deployed and expanded from this back panel towards the driver's seat, and wherein the attachment center S of the inflator to this back panel is set with respect to the center P of the back panel so as to be close to the 6 o'clock direction side in the 12 o'clock direction and the 6 o'clock direction of the steering wheel.

Abstract: An airbag includes first and second inner tethers, first and second vent holes formed on left and right sides of the airbag, and first and second opening/closing members capable of opening/closing the first and second vent holes. A first opening/closing tether has a first end portion coupled to the first opening/closing member and a second end portion coupled to the first inner tether, and a second opening/closing tether has a first end portion coupled to the second opening/closing member and a second end portion coupled to the second inner tether. When an occupant contacts the airbag, at least one of the first and second inner tethers is deformed to move at least one of the first and second opening/closing tethers toward the corresponding vent hole and cause at least one of the first and second opening/closing members to open the corresponding vent hole.

Abstract: Problem: To provide an airbag apparatus which can appropriately control the amount of gas discharged from a vent hole.

Abstract: An airbag device which contributes to reducing an impact on an occupant, while minimizing a loss in inflation gas. The airbag includes first and second inner tethers each having a front panel coupled to a stationary portion around the inflator and a rear panel coupled to an occupant side of the airbag to control a shape into which the airbag is deployed. First and second vent holes are formed on left and right sides of the airbag, first and second opening/closing members capable of opening/closing the first and second vent holes, a first opening/closing tether having an opening/closing end portion coupled to the first opening/closing member and a coupled end portion coupled between the front panel and the rear panel of the first inner tether. A second opening/closing tether having an opening/closing end portion coupled to the second opening/closing member and a coupled end portion coupled between the front panel and the rear panel of the second inner tether.

Abstract: There are disclosed a 1-azabicyclo[3.3.0]octan derivative of the formula ##STR1## wherein n is an integer of 1-5; and Ar is an aromatic residue. a pharmacologically acceptable salt of the compound, a process for the preparation of the compound and salt as well as use thereof as hypermotility agents.

Abstract: There is disclosed a compound shown by a formula of ##STR1## wherein R.sub.1 is a hydrogen atom alkyl group having 1-4 carbon atoms or acyl group having 1-4 carbon atoms: R.sub.2 and R.sub.3 are a hydrogen atom, alkyl group having 1-4 carbon atoms, phenyl radical, halogen atom, cyano radical, acyl group having 1-4 carbon atoms, nitro radical, alkoxy group having 1 or 2 carbon atoms, or substituted or non-substituted amino group, respectively; n is an integer of 1-3; and dotted line means a possible ring, and a salt thereof. The compound and salt bind with muscarinic receptor in brain to develop a powerful actuation thereof and thus those can be used as an effective ingredient for preventing and curing senile dementias, and more particularly Alzheimer's disease.

Abstract: There are disclosed a benzopyrancarboxamide derivative of the formula ##STR1## wherein R.sup.1 is hydrogen atom or a lower alkyl group; R.sup.2 is hydrogen atom, a lower alkyl group, halogen atom, an amino radical or an acylamino group; R.sup.3 is hydrogen atom, a lower alkyl group, a lower alkoxy group or halogen atom; dotted line is a possible double bond; and n is an integer of 1-5,and a pharmacologically acceptable salt of the compound, a process for the preparation of the compound and salt as well as use thereof.

Abstract: There are disclosed a benzo[b]furancarboxamide derivative of the formula ##STR1## wherein R.sup.a, R.sup.b, R.sup.c and R.sup.d are a hydrogen atom or lower alkyl group, respectively; R.sup.e is a hydrogen atom, amino radical, lower alkylamino group or acylamino group; X is a hydrogen atom or halogen atom; and n is an integer of 1-5,and including racemic compounds and stereo-isomers thereof, a salt of the compounds, a process for the preparation of the compounds and salts as well as use thereof for improving hypermotility.

Abstract: An aromatic amino-substituted compound represented by formula: ##STR1## wherein A represents CH, N, or N.fwdarw.O; R.sub.1 represents a nitro group or an amino group; R.sub.2 represents a hydrogen atom, a lower alkyl group, or an acyl group; and R.sub.3 represents a group: ##STR2## wherein m represents 0 or 1; n represents an integer of from 0 to 3; R.sub.4 and R.sub.5 each represents a hydrogen atom or a lower alkyl group; R.sub.6 and R.sub.7 each represents a hydrogen atom or a straight chain or branched lower alkyl group; R.sub.4 and R.sub.6 may be joined together to form an alkylene chain forming a heterocyclic ring; R.sub.5 and R.sub.7 may be joined together to form an alkylene chain forming a heterocyclic ring and R.sub.6 and R.sub.

Abstract: The invention provides a novel glycoside which contains as the aglycon a 4-(substituted phenyl)piperazine-1-yl derivative of glycyrrhetinic acid and 11-deoxo-glycyrrhetinic acid or their derivative as well as a composition for the treatment of virus infection, which contains these compounds as a main active component.

Abstract: A biaxial oriented polyester film of the present invention has a density of 1.386 g/cm.sup.3 or more. A sum Y of the coefficients of the heat shrinkage in the machine direction and in the transverse direction of the film at a temperature of 150.degree. C. is 4.5% or more, and a sum X (kg/mm.sup.2) of F.sub.5 values in the machine direction and in the transverse direction of the film and the sum Y satisfy the following expression (I):Y.sup.2 +3.2Y.gtoreq.19.2X-393.6 (I)wherein the F.sub.5 value refers to an applied force required for extending a film by 5%.

Abstract: An organogermanium compound of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are hydrogen atom, alkyl, substituted alkyl, phenyl or substituted phenyl, and R.sub.5 is a radical of ##STR2## n is an integer of 2 or more, and R.sub.6 and R.sub.7 are hydrogen atom, alkyl, substituted alkyl, phenyl or substituted phenyl,a salt of the compound, a processs for the preparation of the compound as well as a use of the compound as an affective ingredient for pharmaceutical preparations.

Abstract: A cephalosporin derivative represented by the formula ##STR1## wherein R is an organic residue known on .beta.-lactam antibiotics and Q is a radical of ##STR2## dotted-line means a possible double bond, R.sub.1 is hydrogen or monovalent substituent, R.sub.2, R.sub.3 and R.sub.4 are mono-valent substituent, respectively,a salt thereof, a process for the manufacture thereof and a pharmaceutical agent comprising same.

Abstract: There is disclosed novel eburnamonine oxime, its derivatives and salts, process for the manufacture thereof and pharmaceutical agents containing the same. The compounds are represented by the following formula. ##STR1## wherein R is hydrogen, alkyl, alkoxyalkyl, or oxisilanylalkyl group or a group of ##STR2## R.sup.1 and R.sup.2 are same or different and respectively hydrogen, alkyl having 1 to 4 carbon atoms, aryl or aralkyl group, or R.sup.1 represents together with R.sup.2 and the neighboring nitrogen atom a non-substituted or substituted heterocyclic ring, and n is an integer of 2 or 3.

Abstract: A 2,5-benzodiazocine derivative represented by a formula ##STR1## wherein R.sub.1 is phenyl or p-methoxyphenyl, R.sub.2 is hydrogen or methyl, and R.sub.3 is p-methoxyphenethyl, 3-(p-fluorobenzoyl)-propyl, cyclopropylmethyl or ##STR2## or a salt of such novel compound as well as a CNS-active pharmaceutical agent containing as an effective component at least one of said derivatives and salts.

Abstract: Process for the preparation of tropane alkaloids, more particularly of N-acyl-dehydronortropinones, dehydrotropine and tropine. The compounds can be prepared by cyclocoupling N-acyl-pyrrole with .alpha.,.alpha.'-halogenoketone in the presence of a reducing agent and, if necessary, subjecting the resulting N-acyl-dehydronortropinone to either partial reduction and then stereo-selective reduction, or stereo-selective reduction and then partial reduction.